Skip to content

Drug interactions

Nilotinib + Triclabendazole

Severity: Major

Nilotinib and Triclabendazole: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, so taking them together may increase the risk of torsades de pointes. The risk is greater with electrolyte abnormalities or underlying heart disease.

What this interaction means in plain words

Nilotinib and Triclabendazole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Nilotinib belongs to Oncology; Triclabendazole belongs to Anti Parasitic.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Check ECG and correct potassium and magnesium before treatment. Monitor ECG during co-therapy, or defer triclabendazole if the QTc is already prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilotinib and Triclabendazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Nilotinib with Triclabendazole?

MediHelp rates the interaction as major. Nilotinib and Triclabendazole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can prolong the QT interval, so taking them together may increase the risk of torsades de pointes. The risk is greater with electrolyte abnormalities or underlying heart disease.

How serious is the interaction between Nilotinib and Triclabendazole?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG and correct potassium and magnesium before treatment. Monitor ECG during co-therapy, or defer triclabendazole if the QTc is already prolonged.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in